Homocysteine and inflammation: Predictors of cognitive decline in older persons?

Neurobiology of Aging

Volumn 31, Issue 10, 2010, Pages 1700-1709

  van den Kommer, T N ^a   Dik, M G ^a   Comijs, H C ^a   Jonker, C ^a   Deeg, D J H ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cognitive decline; Homocysteine; Inflammation; Longitudinal population based study

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; C REACTIVE PROTEIN; HOMOCYSTEINE; INTERLEUKIN 6;

AGED; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; INFLAMMATION; INTELLIGENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEMORY CONSOLIDATION; PRIORITY JOURNAL; RISK FACTOR; SHORT TERM MEMORY;

AGED; AGED, 80 AND OVER; AGING; ALPHA 1-ANTICHYMOTRYPSIN; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COGNITION; COGNITION DISORDERS; HOMOCYSTEINE; HUMANS; INTERLEUKIN-6; LONGITUDINAL STUDIES; MALE; NEUROPSYCHOLOGICAL TESTS; RISK FACTORS;

EID: 77955842616     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2008.09.009     Document Type: Article

References (65)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders 1994, American Psychiatric Association, Washington DC. 4th ed.
2. Baron R., Harpaz I., Nemirovsky A., Cohen H., Monsonego A. Immunity and neuronal repair in the progression of Alzheimer's disease: a brief overview. Exp. Gerontol. 2007, 42:64-69.
3. Bates C.J., Mansoor M.A., van der Pols J., Prentice A., Cole T.J., Finch S. Plasma total homocysteine in a representative sample of 972 British men and women aged 65 and over. Eur. J. Clin. Nutr. 1997, 51:691-697.
4. Beekman A.T.F., Deeg D.J.H., van Limbeek J., Braam A.W., de Vries M.Z., van Tilburg W. Criterion validity of the Center for Epidemiologic Studies Depression scale (CES-D): results from a community-based sample of older subjects in the Netherlands. Psychol. Med. 1997, 27:231-235.
5. Bremmer M.A., Hoogendijk W.J.G., Deeg D.J.H., Schoevers R.A., Schalk B.W.M., Beekman A.T.F. Depression in older age is a risk factor for first ischemic cardiac events. Am. J. Geriatr. Psychiatry 2006, 14:523-530.
6. Bruins P., te Velthuis H., Yazdanbakhsh A.P., Jansen P.G., van Hardevelt F.W., de Beaumont E.M., Wildevuur C.R., Eijsman L., Trouwborst A., Hack C.E. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 1997, 96:3542-3548.
7. Clarke R., Smith A.D., Jobst K.A., Refsum H., Sutton L., Ueland P.M. Folate, vitamin B-12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch. Neurol. 1998, 55:1449-1455.
8. Clarke R., Lewington S., Donald A., Johnston C., Refsum H., Stratton I., Jacques P., Breteler M.M., Holman R. Underestimation of the importance of homocysteine as a risk factor for cardiovascular disease in epidemiological studies. J. Cardiovasc. Risk 2001, 8:363-369.
9. Deeg D.J., van Tilburg T., Smit J.H., de Leeuw E.D. Attrition in the Longitudinal Aging Study Amsterdam. The effect of differential inclusion in side studies. J. Clin. Epidemiol. 2002, 55:319-328.
10. Dhonukshe-Rutten R.A.M., Pluijm S.M.F., de Groot L.C.P.G., Lips P., Smit J.H., van Staveren W. Homocysteine and vitamin B-12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people. J. Bone Miner. Res. 2005, 20:921-929.
11. Dik M.G., Jonker C., Hack C.E., Smit J.H., Comijs H.C., Eikelenboom P. Serum inflammatory proteins and cognitive decline in older persons. Neurology 2005, 64:1371-1377.
12. Dufouil C., Alperovitch A., Ducros V., Tzourio C. Homocysteine, white matter hyperintensities, and cognition in healthy elderly people. Ann. Neurol. 2003, 53:214-221.
13. Durga J., van Tits L.J., Schouten E.G., Kok F.J., Verhoef P. Effect of lowering of homocysteine levels on inflammatory markers: a randomized controlled trial. Arch. Intern. Med. 2005, 165:1388-1394.
14. Elias M.F., Sullivan L.M., D'Agostino R.B., Elias P.K., Jacques P.F., Selhub J., Seshadri S., Au R., Beiser A., Wolf P.A. Homocysteine and cognitive performance in the Framingham offspring study: age is important. Am. J. Epidemiol. 2005, 162:644-653.
15. Engelhart M.J., Geerlings M.I., Meijer J., Kiliaan A., Ruitenberg A., van Swieten J.C., Stijnen T., Hofman A., Witteman J.C.M., Breteler M.M.B. Inflammatory proteins in plasma and the risk of dementia: the Rotterdam study. Arch. Neurol. 2004, 61:668-672.
16. Feng L., Ng T.P., Chuah L., Niti M., Kua E.H. Homocysteine, folate, and vitamin B-12 and cognitive performance in older Chinese adults: findings from the Singapore Longitudinal Ageing Study. Am. J. Clin. Nutr. 2006, 84:1506-1512.
17. Figueiras A., Domenech-Massons J.M., Cadarso C. Regression models: calculating the confidence interval of effects in the presence of interactions. Stat. Med. 1998, 17:2099-2105.
18. Folstein M.F., Folstein S.E., McHugh P.R. Mini-Mental State. A practical method for grading cognitive state of patients for the clinician. J. Psychiatr. Res 1975, 12:189-198.
19. Friedewald W.T., Levy R.I., Frederickson D.S. Estimation of concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin. Chem. 1972, 18:499-502.
20. Garcia A., Haron Y., Pulman K., Hua L., Freedman M. Increases in homocysteine are related to worsening of stroop scores in healthy elderly persons: a prospective follow-up study. J. Gerontol. A: Biol. Sci. Med. Sci. 2004, 59:1323-1327.
21. Gori A.M., Corsi A.M., Fedi S., Gazzini A., Sofi F., Bartali B., Bandinelli S., Gensini G.F., Abbate R., Ferrucci L. A proinflammatory state is associated with hyperhomocysteinemia in the elderly. Am. J. Clin. Nutr. 2005, 82:335-341.
22. Gori A.M., Sofi F., Marcucci R., Giusti B., Gensini G.F., Abbate R. Association between homocysteine, vitamin B6 concentrations and inflammation. Clin. Chem. Lab. Med. 2007, 45:1728-1736.
23. Gunstad J., Bausserman L., Paul R.H., Tate D.F., Hoth K., Poppas A., Jefferson A.L., Cohen R.A. C-reactive protein, but not homocysteine, is related to cognitive dysfunction in older adults with cardiovascular disease. J. Clin. Neurosci. 2006, 13:540-546.
24. Haan M.N., Miller J.W., Aiello A.E., Whitmer R.A., Jagust W.J., Mungas D.M., Allen L.H., Green R. Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento Area Latino Study on Aging. Am. J. Clin. Nutr. 2007, 85:511-517.
25. Havekes L.M., de Knijff P., Beisiegel U., Havinga J., Smit M., Klasen E. A rapid micromethod for apolipoprotein E phenotyping directly in serum. J. Lipid Res. 1987, 28:455-463.
26. Jolles J., Verhey F.R.J., Riedel W.J., Houx P.J. Cognitive impairment in elderly people. Predisposing factors and implications for experimental drug studies. Drugs Aging 1995, 7:459-479.
27. Kado D.M., Karlamangla A.S., Huang M.H., Troen A., Rowe J.W., Selhub J., Seeman T.E. Homocysteine versus the vitamins folate, B-6, and B-12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur studies of successful aging. Am. J. Med. 2005, 118:161-167.
28. Kalmijn S., Launer L.J., Lindemans J., Bots M.L., Hofman A., Breteler M.M.B. Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam Study. Am. J. Epidemiol. 1999, 150:283-289.
29. Kelly P.J., Kistler J.P., Shih V.E., Mandell R., Atassi N., Barron M., Lee H., Silveira S., Furie K.L. Inflammation, homocysteine, and vitamin B6 status after ischemic stroke. Stroke 2004, 35:12-15.
30. Klee G.G. Cobalamin and folate evaluation: Measurement of methylmalonic acid and homocysteine vs. vitamin B(12) and folate. Clin. Chem. 2000, 46:1277-1283.
31. Klerk M., Durga J., Schouten E.G., Kluft C., Kok F.J., Verhoef P. No effect of folic acid supplementation in the course of 1 year on haemostasis markers and C-reactive protein in older adults. Thromb. Haemost. 2005, 94:96-100.
32. Kriegsman D.M.W., Penninx B.W.J.H., van Eijk J., Boeke A.J.P., Deeg D.J.H. Self-reports and general practitioner information on the presence of chronic diseases in community dwelling elderly. A study on the accuracy of patients' self-reports and on determinations of inaccuracy. J. Clin. Epidemiol. 1996, 49:1407-1417.
33. Lazzerini P.E., Capecchi P.L., Selvi E., Lorenzini S., Bisogno S., Galeazzi M., Laghi P.F. Hyperhomocysteinemia, inflammation and autoimmunity. Autoimmun. Rev. 2007, 6:503-509.
34. Luchsinger J.A., Tang M.X., Shea S., Miller J., Green R., Mayeux R. Plasma homocysteine levels and risk of Alzheimer disease. Neurology 2004, 62:1972-1976.
35. McCaddon A., Hudson P., Davies G., Hughes A., Williams J.H.H., Wilkinson C. Homocysteine and cognitive decline in healthy elderly. Dement. Geriatr. Cogn. Disord. 2001, 12:309-313.
36. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984, 34:939-944.
37. Miller J.W., Green R., Mungas D.M., Reed B.R., Jagust W.J. Homocysteine, vitamin B6, and vascular disease in AD patients. Neurology 2002, 58:1471-1475.
38. Moller J.T., Cluitmans P., Rasmussen L.S., Houx P., Rasmussen H., Canet J., Rabbitt P., Jolles J., Larsen K., Hanning C.D., Langeron O., Johnson T., Lauven P.M., Kristensen P.A., Biedler A., van Beem H., Fraidakis O., Silverstein J.H., Beneken J.E.W., Gravenstein J.S. Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. Lancet 1998, 351:857-861.
39. Mooijaart S.P., Gussekloo J., Frolich M., Jolles J., Stott D.J., Westendorp R.G.J., de Craen A.J.M. Homocysteine, vitamin B-12, and folic acid and the risk of cognitive decline in old age: the Leiden 85-Plus Study. Am. J. Clin. Nutr. 2005, 82:866-871.
40. Newman A.B., Fitzpatrick A.L., Lopez O., Jackson S., Lyketsos C., Jagust W., Ives D., Dekosky S.T., Kuller L.H. Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the cardiovascular health study cohort. J. Am. Geriatr. Soc. 2005, 53:1101-1107.
41. Nilsson K., Hultberg B., Gustafson L. Lack of association between plasma homocysteine and inflammation in psychogeriatric patients. Dement. Geriatr. Cogn. Disord. 2002, 14:151-155.
42. Papatheodorou L., Weiss N. Vascular oxidant stress and inflammation in hyperhomocysteinemia. Antioxid. Redox Signal. 2007, 9:1941-1958.
43. Piccinin A.M., Rabbitt P.M. Contribution of cognitive abilities to performance and improvement on a substitution coding task. Psychol. Aging 1999, 14:539-551.
44. Prins N.D., den Heijer T., Hofman A., Koudstaal P.J., Jolles J., Clarke R., Breteler M.M.B. Homocysteine and cognitive function in the elderly: the Rotterdam Scan Study. Neurology 2002, 59:1375-1380.
45. Quadri P., Fragiacomo C., Pezzati R., Zanda E., Forloni G., Tettamanti M., Lucca U. Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am. J. Clin. Nutr. 2004, 80:114-122.
46. Radloff L.S. The CES-D scale: a self-report depression scale for research in the general population. Appl. Psychol. Meas. 1977, 1:385-401.
47. Ravaglia G., Forti P., Maioli F., Zanardi V., Dalmonte E., Grossi G., Cucinotta D., Macini P., Caldarera M. Blood homocysteine and vitamin B levels are not associated with cognitive skills in healthy normally ageing subjects. J. Nutr. Health Aging 2000, 4:218-222.
48. Ravaglia G., Forti P., Maioli F., Muscari A., Sacchetti L., Arnone G., Nativio V., Talerico T., Mariani E. Homocysteine and cognitive function in healthy elderly community dwellers in Italy. Am. J. Clin. Nutr. 2003, 77:668-673.
49. Ravaglia G., Forti P., Maioli F., Servadei L., Martelli M., Arnone G., Talerico T., Zoli M., Mariani E. Plasma homocysteine and inflammation in elderly patients with cardiovascular disease and dementia. Exp. Gerontol. 2004, 39:443-450.
50. Ravaglia G., Forti P., Maioli F., Montesi F., Rietti E., Pisacane N., Rolfo E., Scali C.R., Dalmonte E. Risk factors for dementia: data from the Conselice Study of brain aging. Arch. Gerontol. Geriatr. 2007, 44:311-320.
51. Ravaglia G., Forti P., Maioli F., Chiappelli M., Montesi F., Tumini E., Mariani E., Licastro F., Patterson C. Blood inflammatory markers and risk of dementia: the Conselice Study of Brain Aging. Neurobiol. Aging 2007, 28:1810-1820.
52. Raven J.C. Manual for the Coloured Progressive Matrices (revised) 1984, NFER-Nelson, Windsor, UK.
53. Reinhard O., Rood-Bakker D. Alcoholgebruik in beeld. Standaardmeetlat 1998, Nederlands Economisch Instituut, Rotterdam, (in Dutch).
54. Rey A. L'examen clinique en psychologie 1964, Presses Universitaire de France, Paris, France.
55. Rozemuller J.M., Abbink J.J., Kamp A.M., Stam F.C., Hack C.E., Eikelenboom P. Distribution pattern and functional state of alpha 1-antichymotrypsin in plaques and vascular amyloid in Alzheimer's disease. A immunohistochemical study with monoclonal antibodies against native and inactivated alpha 1-antichymotrypsin. Acta Neuropathol. 1991, 82:200-207.
56. Selhub J., Miller J.W. The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am. J. Clin. Nutr. 1992, 55:131-138.
57. Seshadri S., Beiser A., Selhub J., Jacques P.F., Rosenberg I.H., D'Agostino R.B., Wilson P.W.F., Wolf P.A. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N. Engl. J. Med. 2002, 346:476-483.
58. Stel V.S., Smit J.H., Pluijm S.M.F., Visser M., Deeg D.J.H., Lips P. Comparison of the LASA Physical Activity Questionnaire with a 7-day diary and pedometer. J. Clin. Epidemiol. 2004, 57:252-258.
59. Teunissen C.E., Blom A.H., van Boxtel M.P., Bosma H., de Bruijn C., Jolles J., Wauters B.A., Steinbusch H.W., de Vente J. Homocysteine: a marker for cognitive performance? A longitudinal follow-up study. J. Nutr. Health Aging 2003, 7:153-159.
60. Tucker K.L., Qiao N., Scott T., Rosenberg I., Spiro A. High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study. Am. J. Clin. Nutr. 2005, 82:627-635.
61. Twisk J.W., de Vente W. Roaming through methodology. XXII. Application of techniques for longitudinal data analysis. Ned. Tijdschr. Geneeskd. 2000, 144:1680-1683.
62. Van den Heuvel N., Smits C. Intelligence: Raven's coloured progressive matrices. Autonomy and Well-Being in the Aging Population I: Report from the Longitudinal Aging Study Amsterdam 1992-1993 1994, 53-58. VU University Press, Amsterdam, The Netherlands. D.J. Deeg, M. Westendorp-de Serière (Eds.).
63. Van den Kommer, T.N., Comijs, H.C., Dik, M.G., Jonker, C., Deeg, D.J., 2008. Development of classification models for early identification of persons at risk for persistent cognitive decline. J. Neurol., doi:10.1007/s00415-008-0942-3.
64. Van Oijen M., de Jong F.J., Witteman J.C.M., Hofman A., Koudstaal P.J., Breteler M.M.B. Atherosclerosis and risk for dementia. Ann. Neurol. 2007, 61:403-410.
65. Yaffe K., Lindquist K., Penninx B.W., Simonsick E.M., Pahor M., Kritchevsky S., Launer L., Kuller L., Rubin S., Harris T. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology 2003, 61:76-80.